82 related articles for article (PubMed ID: 32385165)
1. Receptor-Targeted Photodynamic Therapy of Glucagon-Like Peptide 1 Receptor-Positive Lesions.
Boss M; Bos D; Frielink C; Sandker G; Bronkhorst P; van Lith SAM; Brom M; Buitinga M; Gotthardt M
J Nucl Med; 2020 Nov; 61(11):1588-1593. PubMed ID: 32385165
[TBL] [Abstract][Full Text] [Related]
2. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.
Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B
Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1.
Marzook A; Chen S; Pickford P; Lucey M; Wang Y; Corrêa IR; Broichhagen J; Hodson DJ; Salem V; Rutter GA; Tan TM; Bloom SR; Tomas A; Jones B
Biochem Pharmacol; 2021 Aug; 190():114656. PubMed ID: 34129856
[TBL] [Abstract][Full Text] [Related]
4. 18F-radiolabeled analogs of exendin-4 for PET imaging of GLP-1 in insulinoma.
Kiesewetter DO; Gao H; Ma Y; Niu G; Quan Q; Guo N; Chen X
Eur J Nucl Med Mol Imaging; 2012 Mar; 39(3):463-73. PubMed ID: 22170321
[TBL] [Abstract][Full Text] [Related]
5. Activation of overexpressed glucagon-like peptide-1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression.
Shigeoka T; Nomiyama T; Kawanami T; Hamaguchi Y; Horikawa T; Tanaka T; Irie S; Motonaga R; Hamanoue N; Tanabe M; Nabeshima K; Tanaka M; Yanase T; Kawanami D
J Diabetes Investig; 2020 Sep; 11(5):1137-1149. PubMed ID: 32146725
[TBL] [Abstract][Full Text] [Related]
6. Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study.
Mao D; Cao H; Shi M; Wang CC; Kwong J; Li JJX; Hou Y; Ming X; Lee HM; Tian XY; Wong CK; Chow E; Kong APS; Lui VWY; Chan PKS; Chan JCN
EBioMedicine; 2021 Mar; 65():103242. PubMed ID: 33684886
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons.
Anand U; Yiangou Y; Akbar A; Quick T; MacQuillan A; Fox M; Sinisi M; Korchev YE; Jones B; Bloom SR; Anand P
PLoS One; 2018; 13(5):e0198024. PubMed ID: 29813107
[TBL] [Abstract][Full Text] [Related]
8. Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells.
Fang Z; Chen S; Manchanda Y; Bitsi S; Pickford P; David A; Shchepinova MM; Corrêa IR; Hodson DJ; Broichhagen J; Tate EW; Reimann F; Salem V; Rutter GA; Tan T; Bloom SR; Tomas A; Jones B
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182425
[TBL] [Abstract][Full Text] [Related]
9. Innovative imaging of insulinoma: the end of sampling? A review.
Christ E; Antwi K; Fani M; Wild D
Endocr Relat Cancer; 2020 Apr; 27(4):R79-R92. PubMed ID: 31951592
[TBL] [Abstract][Full Text] [Related]
10. Effects of repeated developmental GLP-1R agonist exposure on young adult behavior and hippocampal structure in mice.
Cerroni C; Steiner A; Seanez L; Kwon S; Lewis AS
Neurosci Lett; 2023 Jun; 808():137299. PubMed ID: 37196974
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas.
Vesterinen T; Peltola E; Leijon H; Hannula P; Huhtala H; Mäkinen MJ; Nieminen L; Pirinen E; Rönty M; Söderström M; Jaatinen P; Arola J
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894845
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule.
Ben Nasr M; Usuelli V; Dellepiane S; Seelam AJ; Fiorentino TV; D'Addio F; Fiorina E; Xu C; Xie Y; Balasubramanian HB; Castillo-Leon E; Loreggian L; Maestroni A; Assi E; Loretelli C; Abdelsalam A; El Essawy B; Uccella S; Pastore I; Lunati ME; Sabiu G; Petrazzuolo A; Ducci G; Sacco E; Centofanti L; Venturini M; Mazzucchelli S; Mattinzoli D; Ikehata M; Castellano G; Visner G; Kaifeng L; Lee KM; Wang Z; Corradi D; La Rosa S; Danese S; Yang J; Markmann JF; Zuccotti GV; Abdi R; Folli F; Fiorina P
Cell Metab; 2024 Jun; 36(6):1302-1319.e12. PubMed ID: 38838642
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4 attenuates atherosclerosis progression via controlling hematopoietic stem/progenitor cell proliferation.
Yan C; Ma X; Lam SM; Zhang Y; Cao Y; Dong Y; Su L; Shui G; Feng Y
J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36866528
[TBL] [Abstract][Full Text] [Related]
14. Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK.
Trachsel B; Valpreda G; Lutz A; Schibli R; Mu L; Béhé M
EJNMMI Radiopharm Chem; 2023 Sep; 8(1):21. PubMed ID: 37665477
[TBL] [Abstract][Full Text] [Related]
15. Application of the Chelator-Based Clickable Radiotheranostic Platform to Moderate-Molecular-Weight Ligands.
Nakashima K; Iikuni S; Watanabe H; Ono M
ACS Med Chem Lett; 2022 Oct; 13(10):1642-1647. PubMed ID: 36262405
[TBL] [Abstract][Full Text] [Related]
16. Site-Specific Dual-Labeling of a VHH with a Chelator and a Photosensitizer for Nuclear Imaging and Targeted Photodynamic Therapy of EGFR-Positive Tumors.
Renard E; Collado Camps E; Canovas C; Kip A; Gotthardt M; Rijpkema M; Denat F; Goncalves V; van Lith SAM
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498707
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma.
Dorst DN; Smeets EMM; Klein C; Frielink C; Geijs D; Trajkovic-Arsic M; Cheung PFY; Stommel MWJ; Gotthardt M; Siveke JT; Aarntzen EHJG; van Lith SAM
Mol Pharm; 2023 Aug; 20(8):4319-4330. PubMed ID: 37485886
[TBL] [Abstract][Full Text] [Related]
18. An Uncommon Cause of Recurrent Presyncope, Dizziness, and Tachycardia: A Case Report of Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS).
Dieterle MP; Husari A; Prozmann SN; Wiethoff H; Stenzinger A; Röhrich M; Pfeiffer U; Kießling WR; Engel H; Sourij H; Steinberg T; Tomakidi P; Kopf S; Szendroedi J
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371836
[TBL] [Abstract][Full Text] [Related]
19. Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic Hypoglycemia.
Dieterle MP; Husari A; Prozmann SN; Wiethoff H; Stenzinger A; Röhrich M; Pfeiffer U; Kießling WR; Engel H; Sourij H; Steinberg T; Tomakidi P; Kopf S; Szendroedi J
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371827
[TBL] [Abstract][Full Text] [Related]
20. Peptide Radioligands in Cancer Theranostics: Agonists and Antagonists.
Nock BA; Kanellopoulos P; Joosten L; Mansi R; Maina T
Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
